Technical requirements, biophysical considerations and protocol optimization with magnetic resonance angiography

Martin Rohrer1, Liesbeth Geerts-Ossevoort, Gerhard Laub

  • 1Business Unit Diagnostic Imaging, Bayer Schering Pharma AG, Berlin, Germany. martin.rohrer@schering.de

European Radiology
|July 26, 2007
PubMed
Summary

Optimizing contrast-enhanced magnetic resonance angiography involves careful selection of hardware, contrast agents, and imaging techniques. Gadolinium agents, like gadofosveset trisodium, enhance vessel visualization by shortening T1 relaxation times.